New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
The positive and negative role of LRH-1 during inflammation

The positive and negative role of LRH-1 during inflammation

by University of KonstanzDetection of immune cells using specific antibodies in tissue sections of the spleen of wild type animals (left panel) and mice with T cell-specific deletion of LRH-1 (ri
Immunology & Rheumatology April 16,2024
The positive and negative role of LRH-1 during inflammation

The positive and negative role of LRH-1 during inflammation

by University of KonstanzDetection of immune cells using specific antibodies in tissue sections of the spleen of wild type animals (left panel) and mice with T cell-specific deletion of LRH-1 (ri
Immunology & Rheumatology April 16,2024
ISG15 deficiency linked to antiviral immunity in humans

ISG15 deficiency linked to antiviral immunity in humans

(HealthDay)—Investigators describe a strategy for development of a broad-spectrum anti-viral agent. Their research was published online May 19 inNature Communications.Noting that studies in mice
Public Health & Prevention April 16,2024
ISG15 deficiency linked to antiviral immunity in humans

ISG15 deficiency linked to antiviral immunity in humans

(HealthDay)—Investigators describe a strategy for development of a broad-spectrum anti-viral agent. Their research was published online May 19 inNature Communications.Noting that studies in mice
Public Health & Prevention April 16,2024
HSPC-derived CAR T-cells capable of lasting engraftment

HSPC-derived CAR T-cells capable of lasting engraftment

(HealthDay)—Hematopoietic stem/progenitor cell (HSPC)-derived chimeric antigen receptor (CAR) T-cells are capable of long-term engraftment in a model of HIV/AIDS, according to a study published online
Immunology & Rheumatology April 16,2024
HSPC-derived CAR T-cells capable of lasting engraftment

HSPC-derived CAR T-cells capable of lasting engraftment

(HealthDay)—Hematopoietic stem/progenitor cell (HSPC)-derived chimeric antigen receptor (CAR) T-cells are capable of long-term engraftment in a model of HIV/AIDS, according to a study published online
Immunology & Rheumatology April 16,2024
JAMA report outlines recommendations for evaluation and management of penicillin allergy

JAMA report outlines recommendations for evaluation and management of penicillin allergy

by Massachusetts General HospitalCredit: CC0 Public DomainWhile more than 32 million individuals in the U.S. have a documented penicillin allergy in their medical record, studies have shown that
Breakthroughs April 16,2024
JAMA report outlines recommendations for evaluation and management of penicillin allergy

JAMA report outlines recommendations for evaluation and management of penicillin allergy

by Massachusetts General HospitalCredit: CC0 Public DomainWhile more than 32 million individuals in the U.S. have a documented penicillin allergy in their medical record, studies have shown that
Breakthroughs April 16,2024
IBD: How a class of killer T cells goes rogue in inflammatory bowel disease

IBD: How a class of killer T cells goes rogue in inflammatory bowel disease

by John Chang,The ConversationThe balance of memory T cell subtypes changes in individuals with ulcerative colitis. Illustrations created with BioRender.com. Credit: John ChangBetween6 and
Gastroenterology April 16,2024
IBD: How a class of killer T cells goes rogue in inflammatory bowel disease

IBD: How a class of killer T cells goes rogue in inflammatory bowel disease

by John Chang,The ConversationThe balance of memory T cell subtypes changes in individuals with ulcerative colitis. Illustrations created with BioRender.com. Credit: John ChangBetween6 and
Gastroenterology April 16,2024
Inflammation can lead to circadian sleep disorders

Inflammation can lead to circadian sleep disorders

by Northwestern UniversityCredit: CC0 Public DomainInflammation, which is the root cause of autoimmune disorders including arthritis, Type 1 diabetes, irritable bowel syndrome and Crohn's dis
Immunology & Rheumatology April 16,2024
Inflammation can lead to circadian sleep disorders

Inflammation can lead to circadian sleep disorders

by Northwestern UniversityCredit: CC0 Public DomainInflammation, which is the root cause of autoimmune disorders including arthritis, Type 1 diabetes, irritable bowel syndrome and Crohn's dis
Immunology & Rheumatology April 16,2024
HIV: an innovative therapeutic breakthrough to optimize the immune system

HIV: an innovative therapeutic breakthrough to optimize the immune system

by Institut national de la recherche scientifique - INRSINRS Professor Julien vanGrevenynghe, expert in immunology and virology, and doctoral student Hamza Loucif, first author of the paper. Cre
Public Health & Prevention April 16,2024
HIV: an innovative therapeutic breakthrough to optimize the immune system

HIV: an innovative therapeutic breakthrough to optimize the immune system

by Institut national de la recherche scientifique - INRSINRS Professor Julien vanGrevenynghe, expert in immunology and virology, and doctoral student Hamza Loucif, first author of the paper. Cre
Public Health & Prevention April 16,2024
IgA antibodies seem to protect unvaccinated against COVID-19

IgA antibodies seem to protect unvaccinated against COVID-19

by University of GothenburgT-cell populations that responded to stimulation with SARS-CoV-2 peptides. PBMC from individuals with IgG-dominated, IgA-dominated, and no antibody response to Covid-19
Public Health & Prevention April 16,2024
IgA antibodies seem to protect unvaccinated against COVID-19

IgA antibodies seem to protect unvaccinated against COVID-19

by University of GothenburgT-cell populations that responded to stimulation with SARS-CoV-2 peptides. PBMC from individuals with IgG-dominated, IgA-dominated, and no antibody response to Covid-19
Public Health & Prevention April 16,2024
How IL-6 allows the immune response to develop for a key cell, the T follicular helper

How IL-6 allows the immune response to develop for a key cell, the T follicular helper

by Jeff Hansen,University of Alabama at BirminghamAndre Ballesteros-Tato. Credit: UABThe body's immune response fights against infectious disease, and it safeguards against future infections
Immunology & Rheumatology April 16,2024
How IL-6 allows the immune response to develop for a key cell, the T follicular helper

How IL-6 allows the immune response to develop for a key cell, the T follicular helper

by Jeff Hansen,University of Alabama at BirminghamAndre Ballesteros-Tato. Credit: UABThe body's immune response fights against infectious disease, and it safeguards against future infections
Immunology & Rheumatology April 16,2024
JAK signaling may be behind polymyalgia rheumatica

JAK signaling may be behind polymyalgia rheumatica

by Lori SolomonJanus tyrosine kinase (JAK) signaling may be involved in the pathogenesis of polymyalgia rheumatica (PMR), and tofacitinib may be an effective treatment, according to a pilot study publ
Immunology & Rheumatology April 16,2024
JAK signaling may be behind polymyalgia rheumatica

JAK signaling may be behind polymyalgia rheumatica

by Lori SolomonJanus tyrosine kinase (JAK) signaling may be involved in the pathogenesis of polymyalgia rheumatica (PMR), and tofacitinib may be an effective treatment, according to a pilot study publ
Immunology & Rheumatology April 16,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com